Figures and Tables Hub
Definitions for early stage unfavourable and favourable Hodgkin lymphoma
Classification, genetic and clinical characteristics of myeloid neoplasms with associated ring sideroblasts
Classification, genetic and clinical characteristics of myeloid neoplasms with associated ring sideroblasts
Common toxicities associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukaemia
ELN 2013 response criteria for patients with chronic myeloid leukaemia treated with a first line tyrosine kinase inhibitor and second line in case of intolerance
ELN 2016 management of toxicities related to tyrosine kinase inhibitors (TKI) used in the treatment of chronic myeloid leukaemia
WHO classification of mastocytosis
WHO criteria for systemic mastocytosis
Key investigation based on the clinical features of systemic mastocytosis
Key morphological and immunophenotyping characteristics of a selection of acute myeloid leukaemia sub-types
Variables and prognostic significance of FLIPI and FLIPI-2 scoring systems in follicular non-Hodgkin lymphoma
Key immunophenotypic markers in the diagnosis of paroxysmal nocturnal haemoglobinuria
Presenting features of Waldenstrom macroglobinaemia
Immunophenotypes and MYD88 prevalence in lymphomas presenting with lymphoplasmacytic differentiation
Hans algorithm for differentiating germinal-centre (GCB) and non-germinal centre (non-GCB) subtypes in diffuse large B-cell lymphoma based on immunohistochemistry expression
Morphological, immunophenotypic and cytogenetic properties of common CD19+/CD20+ lymphoid malignancies
EGIL immunological definition of precursor and mature B-cell malignancies
Chronic myeloid leukaemia disease phases (Vardiman, et al 2002)
WHO criteria for lineage assignment for mixed phenotypic acute leukaemias
Morphological megakaryocyte abnormalities seen in Ph-negative myeloproliferative neoplasms
Morphological characteristics of Ph-negative myeloproliferative neoplasms
Morphological characteristics of essential thrombocythaemia and pre-fibrotic myelofibrosis seen on bone marrow biopsy
British Society for Haematology recommendations for the treatment of MDS with del(5q)
Deauville 5-point scoring system for FDG PET reporting in lymphoma
WHO definition of primary myelofibrosis
Prognostic scores in primary myelofibrosis: MIPSS, MIPSS70+, GIPSS
Cytogenetic abnormalities sufficient to diagnose AML with myelodysplasia-related changes when ≥20% blood or bone marrow blasts are present and prior therapy has been excluded
WHO diagnostic criteria for polycythaemia vera
Diagnostic criteria for Essential Thrombocythaemia (ET) from the 2016 revision WHO revision
IPSS scoring system and prognostic significance in myelodysplastic syndrome
Revised IPSS scoring system and prognostic significance in myelodysplastic syndrome
Variant acute pro-myelocytic leukaemias and sensitivity to ATRA therapy
Morphological abnormalities in myelodysplastic syndrome
Characteristics of hairy cell leukaemia and hairy cell leukaemia variant
Hairy cell leukaemia score using CD11c, CD25, CD103 and CD123
Incidence of autoimmune cytopenias in patients with chronic lymphocytic leukaemia
Immunophenotypic distinction between chronic lymphocytic leukaemia (CLL) and B-lineage prolymphocytic leukaemia (B-PLL)
Cytogenetic and molecular abnormalities associated with primary eosinophilias
Prognostic factors in childhood acute lymphoblastic leukaemia
International prognostic score (Hasenclever index) for Hodgkin lymphoma
British Society for Haematology: salvage chemotherapy outcomes in relapsed Hodgkin lymphoma
Characteristics of hairy cell leukaemia and hairy cell leukaemia variant
British Society for Haematology: pre‐treatment investigations and staging for primary central nervous system lymphoma
British Society for Haematology: management of mantle cell lymphoma
European leukaemia net criteria for hydroxycarbamide intolerance and resistance
British Society for Haematology: classification of post-transplant lymphoproliferative disorders
British Society for Haematology: management of transient leukaemia of down syndrome
British Society for Haematology: viral infections
British Society for Haematology: immunodeficiency scoring index for patients with respiratory syncytial virus infection post-allogeneic haematopoietic stem cell transplant
European leukaemia.net: management of most common treatment-related complications in acute promyelocytic leukemia 
Staging systems for chronic lymphocytic leukaemia
British Society for Haematology: radiological modalities in myeloma
British Society for Haematology: immunophenotypic characteristics of NLPHL, cHL and THRLBCL
Diagnostic criteria for veno-occlusive disease
British Society for Haematology: antiviral agents used in the treatment of CMV infection
British Society for Haematology: periods of severe immunosuppression and associated common pathogens in myeloma patients
British Society for Haematology: definitions of frailty, disability and co-morbidity
European leukaemia.net definitions of accelerated and blast phase CML
European leukaemia.net recommendations for diagnostic work-up, assessment of response and monitoring in CML
Staging and risk assessment in CML
CML cytogenetic and molecular response definitions
Hans algorithm for differentiating germinal-centre (GCB) and non-germinal centre (non-GCB) subtypes in diffuse large B-cell lymphoma based on immunohistochemistry expression
Morphological, immunophenotypic and cytogenetic properties of common CD19+/CD20+ lymphoid malignancies
Morphological megakaryocyte abnormalities seen in Ph-negative myeloproliferative neoplasms
WHO bone marrow reticulin grading system
Morphological characteristics of Ph-negative myeloproliferative neoplasms
Morphological characteristics of essential thrombocythaemia and pre-fibrotic myelofibrosis seen on bone marrow biopsy
Assessment of treatment response in lymphoma based on PET scanning
Prognostic factors in childhood acute lymphoblastic leukaemia
British Society for Haematology: diagnostic criteria for polycythaemia vera
Prognostic scores in primary myelofibrosis: IPSS, DIPSS, DIPSS+
Classification of chronic myelomonocytic leukeamia (CMML) based on blast percentage and total white cell count (WCC)
CNS International Prognostic Index in Diffuse Large B-cell Lymphoma (CNS-IPI)
WHO diagnostic criteria for essential thrombocythaemia
Characteristics of MDS and MPN-like Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
International consensus statement criteria for the classification criteria for antiphospholipid syndrome
Wells predictive tool for deep vein thrombosis
Platelet count monitoring recommendations for patients treated with heparin
Quantitative changes in haemostatic proteins during pregnancy
Inheritance patterns and risk in congenital haemophilia
Different progestins based on time to market introduction
Other thrombocytopenia conditions and their associated features
Coagulation screen interpretation
Hereditary macrothrombocytopenia conditions and their associated features
British Society for Haematology: risk factors for inhibitor formation in congenital haemophilia
British Society for Haematology: potential factors that affect the outcome of immune toleration induction in congenital haemophilia
Predictive model for chemotherapy-associated venous thromboembolism
Classification of von Willebrand disease
Desmopressin characteristics
5T heparin induced thrombocytopenia scoring system
British Society for Haematology: anticoagulant use in heparin induced thrombocytopenia
British Society for Haematology: drugs, compounds and dietary components/herbs that can affect platelet function
British Society for Haematology: agonists for light transmission aggregometry
British Society for Haematology: typical examples of normal & abnormal aggregometry curves in various defects
British Society for Haematology: minimal diagnostic criteria for various platelet defects (1)
British Society for Haematology: minimal diagnostic criteria for various platelet defects (2)
British Society for Haematology: doses of low molecular weight heparin and unfractionated heparin used in children with cancer
British Society for Haematology: causes of disseminated intravascular coagulation
British Society for Haematology: DIC scoring system
Modified WHO bleeding score
British Society for Haematology: procedure based platelet thresholds
British Society for Haematology: presenting clinical features and signs in acute TTP
British Society for Haematology: key investigations and features in the diagnosis of TTP
British Society for Haematology: treatment of acute TTP
British Society for Haematology: differential diagnosis of haemolytic uraemic syndrome
British Society for Haematology: recommended time interval to discontinue direct oral anticoagulants before surgery/invasive procedure
British Society for Haematology: elimination half-lives of antithrombotic drugs
Summary of important anticoagulant properties and reversal strategies
Dosing schedules for common anticoagulants used in the management of Venous Thrombosis
Hereditary macrothrombocytopenia conditions and their associated features
British Society for Haematology: treatment related risk factors for inhibitor formation in congenital haemophilia
Clinical features of Chediak-Higashi syndrome
British Society for Haematology: TRALI v TACO – clinical features and investigation
Evaluation of initial antibody identification panel based on the result of the autoantibody
Donath-Landsteiner test method for paroxysmal cold haemoglobinuria
Hepatitis B serology interpretation
Hepatitis B viral structure
Estimated risk of hepatitis B virus, hepatitis C virus and HIV entering the blood supply from all donations, UK 2010–2012
Storage temperatures and shelf lives of blood components (JPAC)
Effect of proteolytic enzyme treatment according to blood group
ISBT blood component label guide
ABO transfusion selection post allogeneic stem cell transplantation
Definitions of major, minor and bidirectional ABO incompatibility
Definitions of major and minor RhD incompatibility and RhD selection post allogeneic stem cell transplant
Red cell component specifications for intrauterine transfusion (JPAC)
A summary of key organisations/legislation involved in the delivery of safe blood in the United Kingdom
Forward and reverse grouping interpretation of ABO and RhD red cells antigens
Common ABO forward and reverse discrepancies
British Society for Haematology: blood component use in major haemorrhage in adults
British Society for Haematology: practical algorithm for the management of major haemorrhage
British Society for Haematology: details required on blood samples for the transfusion laboratory
British Society for Haematology: laboratory investigation of acute transfusion reactions
British Society for Haematology: indications for transfusion in sickle cell disease
British Society for Haematology: suggested approach to transfusion in critical care
British Society for Haematology: changes in red cell related parameters in critical illness
British Society for Haematology: recognition and initial management of suspected transfusion reaction
Comparison of IgG and IgM red cell alloantibody characteristics
Rh blood group Weiner and Fisher-Race classification
Hierarchy for selection of granulocytes by ABO blood group
Relative proportions of HbA, HbA2 and HbF in β thalassaemias
Relative proportions of HbA and HbH in α thalassaemias
Camitta criteria for aplastic anaemia
Indications for Eculizumab therapy as defined by the UK national PNH service
Monocytic immunophenotypic profiles based on degrees of maturity
Key features distinguishing leukaemoid reactions from chronic myeloid leukaemia
Congenital causes of raised HbF
Acquired causes of raised HbF
WHO bone marrow reticulin grading system
Haemoglobin structure and relative globin proportions at birth and after 6 months age
Algorithm for differentiating compound heterozygous states in HbS, HbC and HbE
Laboratory assays of vitamin B12
Morphological appearance of Langerhan cell and Foreign body granulomas
Common causes of bone marrow granulomas
Cairo-Bishop definition of tumour lysis syndrome
Immunophenotypic patterns of B-lymphocytes/haematogones at different stages of development
Morphological features associated with sickle cell anaemia
Distinguishing features between iron deficiency anaemia, thalassaemia trait and anaemia of chronic disease
Life cycle of plasmodium falciparum
Laboratory tests in the diagnosis of infectious mononucleosis caused by Epstein Barr virus
Pathophysiology of cold haemogluttinin disease
Distinguishing features of varying haemolytic disorders
Clinical and genetic features of molecularly defined congenital sideroblastic anaemias
Causes of leukaemoid reaction
Broad definitions of bacterial sub-groups based on their shape and arrangement
Differential diagnosis of leukaemoid reaction, chronic myelogenous leukaemia, and chronic neutrophilic leukaemia
Histiocytic society diagnostic criteria for HLH
Grading scheme for assessing cardiac iron by MRI T2*
Morphological features associated with plasma cell proliferations
Stages of erythroid maturation
Characteristics of common iron chelators used in clinical practice
British Society for Haematology: drug-induced immune haemolytic anaemia
Red cell morphological abnormalities
British Society for Haematology: classification of autoimmune haemolytic anaemia
British Society for Haematology: diagnostic approach to suspected autoimmune haemolytic anaemia
British Society for Haematology: differential diagnosis of haemolytic anaemia
British Society for Haematology: investigations for autoimmune haemolytic anaemia
British Society for Haematology: serological features of autoimmune haemolytic anaemia and cold agglutinins
British Society for Haematology: causes of eosinophilia
British Society for Haematology: rare iron loading conditions
British Society for Haematology: causes of erythrocytosis
British Society for Haematology: causes of erythrocytosis
British Society for Haematology: investigations required in suspected AL amyloidosis
British Society for Haematology: staging and risk assessment in chronic lymphocytic leukaemia
Purine catabolism
British Society for Haematology: evaluation of end organ involvement in amyloidosis
British Society for Haematology: common causes of hyperferritinaemia
British Society for Haematology: investigation of raised ferritin
Common causes of bone marrow granulomas
Morphological appearance of Langerhan cell and Foreign body granulomas
British Society for Haematology - diagnostic pathway for investigation of erythrocytosis
British Society for Haematology: Treatment of acquired severe aplastic anaemia (2015)
British Society for Haematology: Treatment of adult refractory severe aplastic anaemia (2015)
Features of Niemann-Pick syndrome
Causes of acanthocytes and their associated features
Fungal infections seen in blood and bone marrow
Cryoglobulin classification
Congenital and acquired causes of raised HbF
Causes of mildly raised HbA2
Congenital causes of bone marrow foam cells
start learning today